Processa Pharmaceuticals Azioni (NASDAQ: PCSA)

Ultime notizie per Processa Pharmaceuticals (NASDAQ:PCSA) Azioni

PROCESSA PHARMACEUTICALS INC

Processa Pharma

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Processa Pharmaceuticals, Inc. - Common Stock

Processa Pharmaceuticals Inc

Health care stocks including UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), Elevance Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) and CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) are tanking in Wednesday's extended trading after the Centers for Medicare &amp; Medicaid Services (CMS) announced a significant expansion of its auditing efforts for <a href="https://www.benzinga.com/content/45529802/unitedhealth-insiders-double-down-is-unh-stock-a-value-play">Medicare Advantage (MA) plans. </a>
The Details: The Centers for Medicare &amp; Medicaid Services said <a href="https://www.cms.gov/newsroom/press-releases/cms-rolls-out-aggressive-strategy-enhance-and-accelerate-medicare-advantage-audits">it will audit</a> all eligible MA contracts for each payment year in newly initiated audits and invest additional resources to expedite the completion of audits in its backlog. 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/05/45524565/nvidias-1-trillion-comeback-shows-deepseek-no-longer-spooks-wall-street?utm_source=articleShare">Nvidia&#8217;s $1 Trillion Comeback Shows DeepSeek No Longer Spooks Wall Street&nbsp;</a>
"We are committed to crushing fraud, waste and abuse across all federal healthcare programs," said Dr. Mehmet Oz, CMS Administrator.&nbsp;
"While the Administration values the work that Medicare Advantage plans do, it is time CMS faithfully executes its duty to audit these plans and ensure they are billing the government accurately for the coverage they provide to Medicare patients," Dr. Oz added.&nbsp;
The Trump administration will deploy advanced technology, expand the CMS workforce from 40 to 2,000 medical coders and increase its audit volume to all MA plans each year.&nbsp;
CMS also said that its last significant recovery of MA overpayments occurred following the audit of payment year 2007 and estimates suggest MA plans may overbill the government by approximately $17 billion annually.&nbsp;
CMS will now collaborate with the Department of Health and Human Services Office of Inspector General to recover uncollected overpayments identified in past audits.
UNH, ELV, CVS Price Action: After-hours on Wednesday, UnitedHealth stock was down 3.87% at $291.26, Elevance Health stock was down 1.28% at $394.99 and CVS Health shares were down 4.56% at $59.28 at the time of publication.
Read Also:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45506863/trumps-big-beautiful-bill-advances-heres-who-wins-and-loses?utm_source=articleShare">Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Advances: Here&#8217;s Who Wins And Loses&nbsp;</a></li>
</ul>
Image: Shutterstock

Government

Large Cap

News

Regulations

Health Care

After-Hours Center

Movers

General

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Health Care Stocks Like UnitedHealth, CVS Tank On Wednesday: Here's Why

Gartner (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) has outperformed the market over the past 20 years by 12.67% on an annualized basis producing an average annual return of 20.92%. Currently, Gartner has a market capitalization of $34.09 billion. 
Buying $100 In IT: If an investor had bought $100 of IT stock 20 years ago, it would be worth $4,469.32 today based on a price of $442.91 for IT at the time of writing.
<h3>Gartner's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747863026_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today

NetVRk has launched a new web application for SilkAI, offering browser-based access to interactive non-player characters (NPCs) designed for use across metaverse platforms and robotics applications.
The web app, now live at <a class="" href="https://www.silkai.com">silkai.com</a>, allows users to create, customize and interact with AI-driven characters developed in Unreal Engine 5.
The platform enables real-time deployment of emotionally responsive NPCs, aimed at creators, developers and businesses seeking to embed these agents into digital environments — without relying on centralized AI tools.
According to CEO Michael Katseli, the app is designed to give users "the ability to shape more immersive, personalized digital experiences and own those experiences through blockchain."
SilkAI's web interface supports a range of use cases, including gaming, AI companionship and industrial robotics.
The platform emphasizes interoperability, browser-native functionality and ownership of digital experiences via integration with blockchain-based tools, including its upcoming $SILKAI token.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45549318/bitcoin-whale-trader-ups-the-ante-to-1-billion-position-for-25-million-unrealized-gain-as-btc-sets-all-time-high">Bitcoin Whale Trader Ups The Ante To $1 Billion Position For $25 Million Unrealized Gain As BTC Sets All-Time High</a>
The system is structured around three distinct categories:
<ul class="wp-block-list">
<li>Companion NPCs, featuring voice interaction, gesture-based input, and emotional responsiveness.</li>
<li>Game Engine Integration, supporting high-performance NPCs built for Unreal-based environments.</li>
<li>Industrial Robotics, where avatars assist in real-world machine operations via AI co-pilots.</li>
</ul>
SilkAI is backed by A&amp;P Ventures and Founders, and is supported by partners including ElevenLabs and Packline Robotics. The team behind the platform includes professionals with experience at SpaceX, Microsoft and DIMOCO.
SilkAI will function independently within the NetVRk ecosystem, which allows continued development across both projects. 
The $SILKAI token will enable use across multiple platforms and ecosystems. 
Token listings have already been confirmed on MEXC, WEEX and Aerodrome (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">AERO</a>).
Read Next: • <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45548612/trump-admin-democrats-will-converge-on-crypto-and-it-will-become-more-mainstream-sei-co-founder-says">Trump Admin, Democrats Will Converge On Crypto And It Will Become &#8216;More Mainstream,&#8217; Sei Co-Founder Says</a>
Photo: kkssr via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Tech

$AERO

SilkAI Web App Launch Opens Browser-Based Access To AI-Powered NPCs

Management

MIRA

Mira Pharmaceuticals Michelle Yanez Steps Down As CFO Of Mira Pharmaceuticals; Alan Weichselbaum Appointed As CFO Effective May 15, 2025

WIIM

ZM stock has given up its prior gain. Zoom shares were trading higher after the company reported better-than-expected Q1 earnings and issued upbeat guidance.

<a href="https://www.bloomberg.com/news/articles/2025-05-21/pfizer-hits-fda-setback-in-effort-to-boost-prostate-cancer-drug?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-21/pfizer-hits-fda-setback-in-effort-to-boost-prostate-cancer-drug?embedded-checkout=true</a>

'Pfizer Hits FDA Setback in Effort to Boost Prostate Cancer Drug'- Bloomberg

<a href="https://www.theinformation.com/articles/nike-sell-amazon-first-time-since-2019">https://www.theinformation.com/articles/nike-sell-amazon-first-time-since-2019</a>

AMZN

'Nike to Sell to Amazon For First Time Since 2019'- The Information

Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) has outperformed the market over the past 5 years by 15.52% on an annualized basis producing an average annual return of 29.8%. Currently, Parker Hannifin has a market capitalization of $85.21 billion. 
Buying $1000 In PH: If an investor had bought $1000 of PH stock 5 years ago, it would be worth $3,684.13 today based on a price of $661.78 for PH at the time of writing.
<h3>Parker Hannifin's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747862131_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Parker Hannifin 5 Years Ago Would Be Worth Today

LAZR

Luminar Receives $200M  Capital Commitment to Bolster Balance Sheet & Liquidity

Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares were up nearly 2% on Wednesday before pulling back as the broader market turned lower. Here&#8217;s a look <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour">at what happened</a>.
What To Know: During an interview aired on CNBC's "Closing Bell: Overtime" on Tuesday, Elon Musk stated that Tesla and xAI will continue purchasing "a lot" of GPUs from both Nvidia and AMD, as long as they outperform in-house chip efforts. 
He highlighted xAI's Memphis-based training cluster powered by over 200,000 GPUs and confirmed plans to build a new facility housing one million Nvidia Blackwell GPUs.
The news <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45531583/amd-nvidia-shares-jump-after-musk-highlights-xais-gpu-needs-we-expect-to-still-buy-a-lot">caused a spike</a> in shares of the chip stocks after hours, which carried into Wednesday&#8217;s trading session. 
Separately, AMD announced a lineup of new hardware at Computex 2025, which appeared to spur buying activity in AMD shares. 
The company <a href="https://www.benzinga.com/tech/25/05/45542185/amd-unveils-powerful-new-ai-gaming-chips-at-computex-to-challenge-nvidia">introduced</a> its Radeon RX 9060 XT and Radeon AI PRO R9700 GPUs, built on the RDNA 4 architecture, with a focus on 1440p gaming, AI inference and workstation applications. AMD also launched the Ryzen Threadripper 9000 and 9000 WX-Series processors, aimed at high-end desktops and professional use cases.
Despite the bullish momentum, AMD stock rolled over with the broader market Wednesday afternoon after a<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour"> weak 20-year bond auction</a> led to a spike in Treasury yields above 5.08%. Traders also appeared to react to a new budget bill that could worsen the U.S. deficit. 
AMD Price Action: Despite the strong move in AMD shares to start the day, the stock tumbled in afternoon trading and closed Wednesday&#8217;s session down 1.28% at $112.06, according to<a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2"> Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45551302/5-undervalued-stocks-to-buy-on-china-tariff-cuts">5 Undervalued Stocks To Buy On China Tariff Cuts</a></li>
</ul>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45550679/treasury-yields-top-5-these-20-stocks-tanked-in-just-one-hour">Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour </a></li>
</ul>
Image via Shutterstock.

What Happened To AMD Stock Today?

<a href="https://www.wsj.com/business/media/nbcuniversal-bids-for-mlb-rights-espn-dropped-a98e16c5?msockid=21c662101c496b42343370ae1de86aaa">https://www.wsj.com/business/media/nbcuniversal-bids-for-mlb-rights-espn-dropped-a98e16c5?msockid=21c662101c496b42343370ae1de86aaa</a>

CMCSA

'NBCUniversal Bids for MLB Rights ESPN Dropped'- WSJ

FANG

Diamondback Energy Travis D. Stice To Step Down As Chief Executive Officer; Kaes Van't Hof To Become New CEO, Effective May 21, 2025

Navitas Semiconductor Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares are rocketing higher in after-hours trading Wednesday after the company was selected by NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) to collaborate on next-generation <a href="https://www.benzinga.com/pressreleases/25/05/g45552649/nvidia-selects-navitas-to-collaborate-on-next-generation-800-v-hvdc-architecture">800 V HVDC architecture</a>.
What Happened: After the market close on Wednesday, Navitas announced a collaboration with Nvidia to support Kyber rack-scale systems powering the company&#8217;s GPUs. Nvidia&#8217;s 800V HVDC architecture is focused on high-efficiency, scalable power delivery for next-generation AI workloads.
&#8220;We are proud to be selected by Nvidia to collaborate on their 800 HVDC architecture initiative. Our latest innovations in high-power GaN and SiC technologies have seen world firsts and have created new inflections into markets such as AI datacenters and electric vehicles,&#8221; said Gene Sheridan, co-founder and CEO of Navitas.
&#8220;With our wide portfolio range, we can support NVIDIA&#8217;s 800V HVDC infrastructure, from grid to the GPU.&#8221;
The 800V HVDC directly powers the IT racks and is converted by DC-DC converters to lower voltages, which is expected to drive GPUs, such as the Rubin Ultra. Nvidia&#8217;s 800V HVDC architecture is expected to improve end-to-end power efficiency up to&nbsp;5%, reduce maintenance costs by&nbsp;70% and lower cooling costs.
<h1 class="wp-block-heading">How To Buy NVTS Stock</h1>
By now you're likely curious about how to participate in the market for Navitas — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option or sell a call option at a strike price above where shares are currently trading — either way, it allows you to profit off of the share price decline.
NVTS Price Action: <a href="http://benzinga.com/quote/nvts">Navitas Semiconductor shares</a> were up 224.08% after hours, trading at $6.19 at the time of publication on Wednesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45524565/nvidias-1-trillion-comeback-shows-deepseek-no-longer-spooks-wall-street">Nvidia&#8217;s $1 Trillion Comeback Shows DeepSeek No Longer Spooks Wall Street</a></li>
</ul>
Photo: Shutterstock.

NVDA

NVTS

Navitas Semiconductor Shares Soar On Nvidia Collaboration

RAMP

RAMP stock has given up its prior loss. LiveRamp Holdings shares were trading lower following Q4 financial results.

Guidance

Pitney Bowes Reaffirms Full-Year Financial Guidance Due to the Continued Strength of SendTech and Presort

<h3>Gainers</h3>
<ul>
<li>Star Equity Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRR#NASDAQ">STRR</a>) stock increased by 24.5% to $2.74 during Wednesday's after-market session. The market value of their outstanding shares is at $8.7 million. </li>
<li>Urban Outfitters (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URBN#NASDAQ">URBN</a>) shares increased by 9.07% to $65.01. The market value of their outstanding shares is at $6.0 billion. As per the press release, Q1 earnings came out today. </li>
<li>Jinxin Technology Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAMI#NASDAQ">NAMI</a>) stock increased by 7.14% to $3.3. The company's market cap stands at $225.6 million. </li>
<li>Allurion Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALUR#NYSE">ALUR</a>) shares rose 5.65% to $2.99. The market value of their outstanding shares is at $22.2 million. </li>
<li>Top Win International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOPW#NASDAQ">TOPW</a>) shares rose 5.28% to $9.3. The market value of their outstanding shares is at $231.2 million. </li>
<li>Newegg Commerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) stock moved upwards by 5.26% to $6.01. The company's market cap stands at $117.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Lottery.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRY#NASDAQ">LTRY</a>) stock fell 8.4% to $1.63 during Wednesday's after-market session. The company's market cap stands at $30.7 million. As per the press release, Q1 earnings came out today. </li>
<li>MKDWell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKDW#NASDAQ">MKDW</a>) stock decreased by 7.67% to $0.3. The company's market cap stands at $43.0 million. </li>
<li>U Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCAR#NASDAQ">UCAR</a>) shares decreased by 7.47% to $2.85. The market value of their outstanding shares is at $12.0 million. </li>
<li>Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>) shares fell 5.0% to $110.53. The market value of their outstanding shares is at $6.7 billion. </li>
<li>JX Luxventure Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXG#NASDAQ">JXG</a>) shares fell 4.75% to $2.41. The company's market cap stands at $3.6 million. As per the press release, FY earnings came out 4 days ago. </li>
<li>J-Long Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JL#NASDAQ">JL</a>) shares fell 4.67% to $4.5. The market value of their outstanding shares is at $14.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALUR

LTRY

MKDW

NAMI

NEGG

OLLI

STRR

TOPW

UCAR

URBN

12 Consumer Discretionary Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Longevity Health Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAGE#NASDAQ">XAGE</a>) shares moved upwards by 55.5% to $4.76 during Wednesday's after-market session. The market value of their outstanding shares is at $4.7 million. </li>
<li>SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) shares moved upwards by 15.94% to $2.0. The market value of their outstanding shares is at $18.5 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock rose 9.3% to $0.53. The market value of their outstanding shares is at $6.0 million. </li>
<li>Lipella Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIPO#NASDAQ">LIPO</a>) shares rose 7.26% to $3.1. The company's market cap stands at $13.8 million. </li>
<li>Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) stock moved upwards by 7.2% to $1.99. The market value of their outstanding shares is at $2.9 million. </li>
<li>Immutep (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) stock moved upwards by 6.7% to $2.07. The market value of their outstanding shares is at $301.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Petros Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) shares decreased by 37.0% to $0.04 during Wednesday's after-market session. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>CEL-SCI (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVM#AMEX">CVM</a>) stock declined by 20.4% to $3.59. The company's market cap stands at $326.8 million. The company's, Q2 earnings came out 4 days ago. </li>
<li>Brainstorm Cell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCLI#NASDAQ">BCLI</a>) shares decreased by 12.72% to $1.03. The market value of their outstanding shares is at $5.8 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock fell 12.26% to $0.27. The company's market cap stands at $2.9 million. </li>
<li>BioAtla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCAB#NASDAQ">BCAB</a>) stock decreased by 7.02% to $0.36. The market value of their outstanding shares is at $21.0 million. </li>
<li>Biodesix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDSX#NASDAQ">BDSX</a>) shares decreased by 6.76% to $0.37. The market value of their outstanding shares is at $53.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

BCAB

BCLI

BDSX

BJDX

IMMP

LIPO

PTPI

SABS

VTAK

Longevity Health Holdings, Inc. - Common Stock

XAGE

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Webus International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETO#NASDAQ">WETO</a>) shares moved upwards by 17.7% to $2.79 during Wednesday's after-market session. The market value of their outstanding shares is at $61.3 million. </li>
<li>NeoVolta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOV#NASDAQ">NEOV</a>) stock moved upwards by 8.76% to $3.1. The company's market cap stands at $105.7 million. </li>
<li>Addentax Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>) stock increased by 8.74% to $0.65. The market value of their outstanding shares is at $3.9 million. </li>
<li>American Superconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMSC#NASDAQ">AMSC</a>) shares rose 7.56% to $26.02. The market value of their outstanding shares is at $1.0 billion. The company's, Q4 earnings came out today. </li>
<li>CPI Aerostructures (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CVU#AMEX">CVU</a>) shares rose 7.26% to $3.1. The market value of their outstanding shares is at $40.3 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) shares moved upwards by 5.9% to $0.35. The company's market cap stands at $9.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) shares decreased by 10.7% to $0.15 during Wednesday's after-market session. The company's market cap stands at $4.4 million. </li>
<li>Founder Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGL#NASDAQ">FGL</a>) shares decreased by 5.89% to $0.91. The company's market cap stands at $15.3 million. </li>
<li>Micropolis Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MCRP#AMEX">MCRP</a>) shares fell 5.56% to $2.04. The company's market cap stands at $71.1 million. </li>
<li>Intercont (Cayman) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCT#NASDAQ">NCT</a>) shares declined by 5.35% to $4.78. The company's market cap stands at $129.2 million. </li>
<li>iPower (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPW#NASDAQ">IPW</a>) shares fell 5.01% to $0.47. The market value of their outstanding shares is at $14.9 million. The company's, Q3 earnings came out 4 days ago. </li>
<li>Centuri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRI#NYSE">CTRI</a>) shares declined by 4.26% to $17.61. The market value of their outstanding shares is at $1.5 billion. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMSC

ATXG

CTRI

HTOO

MCRP

NEOV

VSTE

WETO

12 Industrials Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) stock moved upwards by 238.2% to $6.46 during Wednesday's after-market session. The company's market cap stands at $1.2 billion. </li>
<li>LiveRamp Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RAMP#NYSE">RAMP</a>) shares rose 10.01% to $30.88. The market value of their outstanding shares is at $2.0 billion. The company's, Q4 earnings came out today. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) shares increased by 9.05% to $0.59. The market value of their outstanding shares is at $1.1 million. As per the press release, Q1 earnings came out 4 days ago. </li>
<li>Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) shares rose 6.39% to $190.57. The company's market cap stands at $63.6 billion. The company's, Q1 earnings came out today. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) shares moved upwards by 5.88% to $1.08. The company's market cap stands at $27.2 million. </li>
<li>Perfect (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PERF#NYSE">PERF</a>) shares increased by 5.58% to $1.89. The market value of their outstanding shares is at $192.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) stock fell 9.4% to $1.16 during Wednesday's after-market session. The market value of their outstanding shares is at $180.5 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock fell 6.25% to $0.45. The market value of their outstanding shares is at $11.6 million. As per the news, the Q1 earnings report came out 2 days ago. </li>
<li>WISeKey Intl Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKEY#NASDAQ">WKEY</a>) stock decreased by 5.14% to $6.18. The market value of their outstanding shares is at $69.3 million. </li>
<li>LightPath Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) stock declined by 4.73% to $2.22. The company's market cap stands at $93.5 million. The company's, Q3 earnings came out 4 days ago. </li>
<li>Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) stock fell 4.1% to $5.85. The company's market cap stands at $472.6 million. </li>
<li>Glimpse Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRAR#NASDAQ">VRAR</a>) shares fell 3.92% to $1.26. The market value of their outstanding shares is at $26.5 million. As per the news, the Q3 earnings report came out 4 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CLRO

KODK

LPTH

PERF

SNOW

VRAR

WKEY

WOLF

12 Information Technology Stocks Moving In Wednesday's After-Market Session

Pitney Bowes Intends to Execute the Full $150M Share Repurchase Authorization in 2025

Press Releases

Processa Pharmaceuticals Announces Positive Preclinical Data for NGC-Iri

Processa Pharmaceuticals Provides Product Pipeline and Financial Update

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

Comments

Processa Pharmaceuticals

Notizie

Ultime notizie per Processa Pharmaceuticals (NASDAQ:PCSA) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO